Search alternatives:
significant treatment » significant investment (Expand Search), significant enrichment (Expand Search), significant impairment (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
treatment decrease » treatment decreased (Expand Search), treatments decreased (Expand Search), treatment increases (Expand Search)
Showing 341 - 360 results of 5,283 for search '(( significant decrease decrease ) OR ( significant treatment decrease ))~', query time: 0.45s Refine Results
  1. 341
    ZLN005 and metformin toxicity in MAC.

    ZLN005 and metformin toxicity in MAC. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 342
    Full Western blot images from manuscript.

    Full Western blot images from manuscript. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 343
    Metformin rescues PGC-1α expression in presence of inhibitor.

    Metformin rescues PGC-1α expression in presence of inhibitor. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 344
    Metformin increases PGC-1α and TFAM expression.

    Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 345
    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α.

    Metformin and ZLN005 prevent NTM-mediated macrophage dysfunction through PGC-1α. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 346
    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.

    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 347
    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.

    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 348
    NTM infection induces mitochondrial damage and reduces mitochondria number.

    NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 349
    Average activity profiles (columns 1 & 3) and double-plotted actograms (col. 2 & 4) of female and male <i>M. marinus</i> (col. 1 & 2) and <i>G. pulex</i> (col. 3 & 4).

    Average activity profiles (columns 1 & 3) and double-plotted actograms (col. 2 & 4) of female and male <i>M. marinus</i> (col. 1 & 2) and <i>G. pulex</i> (col. 3 & 4). by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 350
    Average activity profiles (left column) and double-plotted actograms (right column) of <i>Marinogammarus marinus</i> (A-B) and <i>Gammarus pulex</i> (C-D) under the LD light regime.

    Average activity profiles (left column) and double-plotted actograms (right column) of <i>Marinogammarus marinus</i> (A-B) and <i>Gammarus pulex</i> (C-D) under the LD light regime... by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 351
    Activity of female and male <i>M. marinus</i> (left column) and <i>G. pulex</i> (right column).

    Activity of female and male <i>M. marinus</i> (left column) and <i>G. pulex</i> (right column). by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 352
    Average activity profiles (columns 1 & 3) and double-plotted actograms (col. 2 & 4) of <i>G. pulex.</i>

    Average activity profiles (columns 1 & 3) and double-plotted actograms (col. 2 & 4) of <i>G. pulex.</i> by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 353
    Behavioural parameters of <i>Marinogammarus marinus</i> and <i>Gammarus pulex</i> activity under varying light/dark cycles.

    Behavioural parameters of <i>Marinogammarus marinus</i> and <i>Gammarus pulex</i> activity under varying light/dark cycles. by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 354
    Average activity profiles (columns 1 & 3) and double-plotted actograms (col. 2 & 4) of <i>M. marinus.</i>

    Average activity profiles (columns 1 & 3) and double-plotted actograms (col. 2 & 4) of <i>M. marinus.</i> by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 355
    Locomotor activity of <i>Marinogammarus marinus</i> (left column) and <i>Gammarus pulex</i> (right column).

    Locomotor activity of <i>Marinogammarus marinus</i> (left column) and <i>Gammarus pulex</i> (right column). by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 356
    Light conditions for behavioural assays. Day phase length included the three-hour transitions at lights on/off, except under constant conditions (LL and DD).

    Light conditions for behavioural assays. Day phase length included the three-hour transitions at lights on/off, except under constant conditions (LL and DD). by Charlotte N. Underwood (5043110)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 357
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 358
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 359
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 360
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: